Cigna Group Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Cigna Group de 9.6% y 8.1% por año respectivamente. Se prevé que el BPA crezca en un 13.9% al año. Se espera que la rentabilidad financiera sea de 17.8% en 3 años.

Información clave

18.0%

Tasa de crecimiento de los beneficios

21.8%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	17.2%
Tasa de crecimiento de los ingresos	7.8%
Rentabilidad financiera futura	19.6%
Cobertura de analistas	Good
Última actualización	06 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being

Apr 18

If EPS Growth Is Important To You, Cigna Group (NYSE:CI) Presents An Opportunity

Jun 18

Cigna: Buy This Value Gem Before It Bounces Back

Jun 12

Returns On Capital At Cigna Group (NYSE:CI) Paint A Concerning Picture

Jun 04

Cigna: Many Reasons To Invest

May 29

An Intrinsic Calculation For The Cigna Group (NYSE:CI) Suggests It's 49% Undervalued

May 21

Is Cigna Group (NYSE:CI) A Risky Investment?

Mar 24

Cigna Corporation: Undervalued For Stable Growth

Feb 23

Do Cigna's (NYSE:CI) Earnings Warrant Your Attention?

Feb 21

Cigna (NYSE:CI) Will Pay A Larger Dividend Than Last Year At $1.23

Feb 06

CIGNA Q4 2022 Earnings Preview

Feb 02

Cigna Corporation Is At A Great Entry Price

Jan 18

Cigna: A Defensive Stock With Multiple Avenues For Growth

Jan 11

Here's Why Cigna (NYSE:CI) Can Manage Its Debt Responsibly

Dec 21

Are Investors Undervaluing Cigna Corporation (NYSE:CI) By 45%?

Nov 27

Cigna Q3: Where I Went Wrong

Nov 07

Previsiones de crecimiento de beneficios e ingresos

NYSE:CI - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	262,043	7,828	12,795	12,874	11
12/31/2025	247,007	7,148	11,349	11,598	16
12/31/2024	235,472	5,153	11,017	11,377	13
3/31/2024	204,145	3,620	10,160	11,625	N/A
12/31/2023	195,187	5,164	10,240	11,813	N/A
9/30/2023	189,856	5,292	10,892	12,445	N/A
6/30/2023	186,021	6,641	11,414	12,902	N/A
3/31/2023	182,808	6,774	10,239	11,654	N/A
12/31/2022	180,031	6,704	7,361	8,656	N/A
9/30/2022	180,028	6,627	9,578	10,832	N/A
6/30/2022	179,185	5,491	8,402	9,668	N/A
3/31/2022	176,986	5,401	6,928	8,128	N/A
12/31/2021	174,267	5,370	6,037	7,191	N/A
9/30/2021	170,397	8,384	6,041	7,210	N/A
6/30/2021	167,028	8,151	4,915	5,986	N/A
3/31/2021	163,141	8,438	8,487	9,556	N/A
12/31/2020	160,550	8,458	9,256	10,350	N/A
9/30/2020	157,009	5,300	7,764	8,849	N/A
6/30/2020	154,629	5,263	9,339	10,415	N/A
3/31/2020	154,168	4,917	7,057	8,180	N/A
12/31/2019	153,743	5,104	8,435	9,485	N/A
9/30/2019	129,660	4,271	5,896	6,818	N/A
6/30/2019	102,510	3,692	4,176	4,981	N/A
3/31/2019	75,145	3,090	4,318	4,937	N/A
12/31/2018	48,569	2,637	3,242	3,770	N/A
9/30/2018	44,969	2,759	3,742	4,219	N/A
6/30/2018	44,001	2,547	4,333	4,830	N/A
3/31/2018	42,949	2,554	4,049	4,532	N/A
12/31/2017	42,043	2,237	N/A	4,086	N/A
9/30/2017	41,332	2,353	N/A	4,358	N/A
6/30/2017	40,723	2,249	N/A	5,035	N/A
3/31/2017	40,258	1,946	N/A	4,684	N/A
12/31/2016	40,007	1,867	N/A	4,026	N/A
9/30/2016	39,252	1,911	N/A	4,315	N/A
6/30/2016	38,761	2,002	N/A	3,017	N/A
3/31/2016	38,293	2,080	N/A	3,117	N/A
12/31/2015	37,876	2,094	N/A	2,933	N/A
9/30/2015	37,276	2,135	N/A	2,319	N/A
6/30/2015	36,644	2,122	N/A	2,175	N/A
3/31/2015	35,885	2,107	N/A	2,241	N/A
12/31/2014	34,914	2,102	N/A	2,158	N/A
9/30/2014	34,098	1,996	N/A	2,084	N/A
6/30/2014	33,407	2,015	N/A	2,444	N/A
3/31/2014	32,654	1,947	N/A	2,014	N/A
12/31/2013	32,380	1,476	N/A	719	N/A
9/30/2013	31,888	1,521	N/A	900	N/A
6/30/2013	31,145	1,434	N/A	-250	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (9.6% al año) de CI es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (18.2% al año) de CI crezcan más rápidamente que el mercado US (14% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de CI crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (7.8% al año) de CI crezcan más despacio que el mercado de US (8.2% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 8.1% al año) de CI crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de CI sea baja dentro de 3 años (17.8%).

Cigna Group Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

The Cigna Group Provides Earnings Guidance for the Fiscal Year 2024

Price target increased to US$348

Consensus forecasts updated

Price target increased to US$337

Recent updates

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Fourth quarter dividend of US$1.40 announced

The Cigna Group Declares Quarterly Dividend, Payable on June 20, 2024

Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being

National Center for Public Files an Exempt Solicitation Statement and Request Vote for the Proposal

Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why

Returns Are Gaining Momentum At Cigna Group (NYSE:CI)

Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018

President notifies of intention to sell stock

The Cigna Group, Annual General Meeting, Apr 24, 2024

Cigna: Trimming The Fat And Staying Focused

Upcoming dividend of US$1.40 per share

Cigna: Big Buybacks And Total Return Potential

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Cigna Group (NYSE:CI) Is Increasing Its Dividend To $1.40

Third quarter dividend increased to US$1.40

Insider notifies of intention to sell stock

The Cigna Group Provides Earnings Guidance for the Fiscal Year 2024

The Cigna Group Declares Cash Quarterly Dividend, Payable on March 21, 2024

Cigna Q4 Preview: The Analysts' Whisper - Deciphering Cigna's Next Big Leap

We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt

the Cigna Group Announces Intention to Retire of Mary Agoglia Hoeltzel as Senior Vice President and Chief Accounting Officer, Effective from July 1, 2024

Why Dividend Growth Investors Should Buy Cigna

The Cigna Group Announces Management Changes

It's A Story Of Risk Vs Reward With The Cigna Group (NYSE:CI)

Cigna Group (NYSE:CI) Is Experiencing Growth In Returns On Capital

Cigna: Sentiment And Fundamentals On Their Side

Insider notifies of intention to sell stock

Investor sentiment improves as stock rises 17%

Cigna's Merger Fumble: A Festive Financial Rebound

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana And Cigna Topple On Rumors Of An Unlikely Union

Cigna and Humana Reportedly in Merger Talks

Cigna Healthcare Appoints Hisham Radwan as Chief Executive Officer of Cigna Insurance Saudi Arabia

Cigna Healthcare Appoints Hisham Radwan as Chief Executive Officer of Cigna Insurance Saudi Arabia

Upcoming dividend of US$1.23 per share at 1.7% yield

The Cigna Group to Report Q2, 2024 Results on Aug 01, 2024

Cigna Delivering Growth At A Great Price

Cigna Reportedly Explores Shedding Medicare Advantage Business

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Cigna Group Declares Quarterly Dividend, Payable on December 21, 2023

Cigna: Too Cheap To Ignore

We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt

Cigna Healthcare Expands 2024 Medicare Advantage Plans Offering Customers More Variety and Value

Cigna: Buy Rating Driven By Undervaluation & Revenue Growth

Cigna Group (NYSE:CI) Is Reinvesting At Lower Rates Of Return

The Cigna Group to Report Q1, 2024 Results on May 02, 2024

Cigna: Seizing Opportunities And Managing Risks In The Healthcare Landscape

Cigna Healthcare Launches New Global Health Benefits Plan for Adults Aged 60+

Insider notifies of intention to sell stock

Upcoming dividend of US$1.23 per share at 1.8% yield

Cigna Group: Weaker Than Peers But Still A Buy

Executive VP & General Counsel notifies of intention to sell stock

Insider recently sold US$2.3m worth of stock

Insider notifies of intention to sell stock

Cigna: Buy During The Next Correction (Technical Analysis)

Second quarter 2023 earnings released: EPS: US$4.96 (vs US$4.95 in 2Q 2022)

The Cigna Group Declares Quarterly Dividend, Payable on September 21, 2023

Executive Vice President of Strategy notifies of intention to sell stock

Cigna Group (NYSE:CI) Has A Pretty Healthy Balance Sheet

Cigna: Buy While It's Still Cheap And Not Loved

The Cigna Group Announces Executive Changes

If EPS Growth Is Important To You, Cigna Group (NYSE:CI) Presents An Opportunity

Cigna: Buy This Value Gem Before It Bounces Back

Returns On Capital At Cigna Group (NYSE:CI) Paint A Concerning Picture

Upcoming dividend of US$1.23 per share at 2.0% yield

Cigna: Many Reasons To Invest

An Intrinsic Calculation For The Cigna Group (NYSE:CI) Suggests It's 49% Undervalued

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Is Cigna Group (NYSE:CI) A Risky Investment?